Develops non-invasive cancer detection tests using ctDNA methylation sequencing and AI-driven imaging analysis to identify early-stage lung, bladder, and gastrointestinal cancers. These tools enable precise diagnosis and monitoring, improving patient outcomes by detecting over 70% of high-incidence cancer types through blood and urine samples.
Funding
Funding not disclosed
Founders
Product
Problem
Early detection of cancers like lung, bladder, and gastrointestinal is challenging due to the limitations of traditional invasive methods and the lack of effective screening tools. Current diagnostic approaches often detect these cancers at later stages, resulting in poorer patient outcomes and increased treatment costs.
Solution
The company develops non-invasive cancer detection tests utilizing circulating tumor DNA (ctDNA) methylation sequencing and AI-driven imaging analysis. These tests aim to identify early-stage lung, bladder, and gastrointestinal cancers from blood and urine samples. The core technology leverages proprietary DNA methylation techniques and AI algorithms to detect cancer-specific epigenetic markers, enabling earlier and more accurate diagnosis. The company offers a range of products for cancer screening, diagnosis, and monitoring, covering over 70% of high-incidence cancer types.
Target Audience
The primary target audience includes healthcare providers, oncologists, and patients at risk for or suspected of having lung, bladder, or gastrointestinal cancers.
Features
- **PulmoSeek™ Plus (费益检®):** A diagnostic product for differentiating between benign and malignant lung nodules.
- **PulmoPath™ (费镜检™):** An assay for aiding in the diagnosis of early-stage lung cancer through methylation detection.
- **PulmoInsight™️ (费影检™️):** A CT image analysis system using AI to assist in the analysis of lung nodules.
- **UriFind® (泌益检™):** A non-invasive methylation test for urothelial carcinoma (UC) detection in urine samples.
- **Gastromia™ (卫益检®):** A diagnostic test for gastrointestinal cancers.
- **AnchorViola®:** Somatic mutation library preparation technology.
- **AnchorIRIS®:** DNA methylation library preparation technology.
- **AnchorMonarch®:** Methylation analysis software.